Oracle (ORCL) is a cheap stock and investors should pay attention to the NetSuite deal discussion when it reports earnings tomorrow, says TheStreet's Jim Cramer. Wall Street seems reasonably optimistic about Oracle's numbers this quarter. It doesn't appear likely that the company will join a list of vulnerable stocks poised for collapse. Analysts predict that Oracle's revenue will increase 3% to $8.70 billion in its fiscal first quarter from $8.45 billion in the year-earlier period. After a 1% drop in fiscal fourth-quarter revenue, Oracle offered a positive fiscal first-quarter outlook.
More from Video
Despite the president's promise of no stimulus until after Nov. 3, there are no signs yet that this is the sort of correlated selling that leads to a deep correction.
Salesforce, Amgen and Honeywell will give a lift to the DJIA going forward.
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.